Every October, we are surrounded by a sea of pink to inspire hope and raise awareness of breast cancer. The month is dedicated to educating the public about breast cancer early detection, causes, prevention, treatment, support services and more. According to the American Cancer Society, breast cancer is the second most common cancer in American […]
September is Prostate Cancer Awareness Month, a time to raise awareness about the risks of prostate cancer and encourage men to take control of their prostate health by getting their regular screenings. Prostate cancer is one of the most common cancers found in American men, second only to skin cancer. In 2020, the American Cancer […]
Forbes Leading the third-largest COVID testing lab in the United States amid a pandemic, was not something Dr. Jon Cohen learned how to do in medical school. His career in healthcare administration and politics didn’t fully prepare him for this experience either. As Executive Chairman of BioReference Lab, Cohen had to apply a critical skill […]
Wall Street Journal BioReference Labs shut down temporarily in July in a controversial move that helped it win new business and prepare for the coming flu season Technicians processed incoming Covid-19 tests at BioReference Laboratories in Elmwood Park, N.J. ELMWOOD PARK, N.J.—In early July, as coronavirus surged across the U.S., one of the nation’s biggest laboratories involved […]
The COVID-19 testing program will test principals, teachers and staff in preparation for a safer back-to-school environment ELMWOOD PARK, N.J., September 2, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today began testing New York City principals, teachers and other staff for COVID-19, across the five boroughs, in preparation for a safer back-to-school environment. Through a […]
ELMWOOD PARK, N.J., September 2, 2020 — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), along with its specialty oncology division, GenPath, today announced the launch of OnkoSight AdvancedTM, a next-generation sequencing (NGS) assay that enables revolutionary deoxyribonucleic acid (DNA) mutational profiling of tumor samples. OnkoSight AdvancedNGS testing provides targeted gene content that is aligned with the latest […]
“On August 22, BioReference Laboratories reported an elevated number of positive COVID-19 PCR test results for NFL players and personnel at multiple clubs. The NFL immediately took necessary actions to ensure the safety of the players and personnel. Our investigation indicated that these were most likely false positive results, caused by an isolated contamination during […]
Mad Money with Jim Cramer (CNBC) “We honed down pretty quickly that we knew it was specimen preparing issue at the very beginning,” Jon Cohen of BioReference said after the NFL had dozens of coronavirus test results re-examined. Click here for original post on Mad Money with Jim Cramer (CNBC)
ELMWOOD PARK, N.J., August 18, 2020 – BioReference Laboratories Inc., an OPKO Health Company, is pleased to announce it is now in-network with all Blue Cross and Blue Shield of Texas (BCBSTX) products, including its Health Maintenance Organization (HMO) and Medicaid lines of business. The contract includes BioReference’s subsidiary GeneDx, Inc., a full service genetics […]
After most schools were cancelled early last spring due to COVID-19, back to school season may be a little different this year. As you round up the notebooks and sharpen the pencils, and get the kids back to their regular classrooms, schedules and teachers, it’s also time to think about regular immunizations. Vaccination throughout childhood […]